dnase i treatment cat. no. mo4501 (SinaClon BioScience)
90
Structured Review
SinaClon BioScience
dnase i treatment cat. no. mo4501
Dnase I Treatment Cat. No. Mo4501, supplied by SinaClon BioScience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dnase+i+treatment+cat%2E+no%2E+mo4501/dnase+i+treatment+cat++no++mo4501/pm36764337-88-11-17
Average 90 stars, based on 1 article reviews
Dnase I Treatment Cat. No. Mo4501, supplied by SinaClon BioScience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dnase+i+treatment+cat%2E+no%2E+mo4501/dnase+i+treatment+cat++no++mo4501/pm36764337-88-11-17
Average 90 stars, based on 1 article reviews
dnase i treatment cat. no. mo4501 - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: Misexpression of LINC01410, FOSL1, and MAFB in peripheral blood mononuclear cells associated with diabetic nephropathy. Article Snippet: Aims: Currently, diabetic nephropathy (DN) is considered the leading cause of the end-stage renal disease (ESRD).. However, its specific molecular mechanism is still unclear, and there is still a lack of effective diagnostic and therapeutic methods.. Method: A pathway was assumed after bioinformatics analysis of GEO datasets related to individuals with various levels of DN, LINC01410, MAFB, and FOSL1. |